MyFinsight
Home
Blog
About
Back
Income Statement
LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc. (LENZ)
source: myfinsight.com
Comprehensive loss
-$32,097K
(-114.02%↓ Y/Y)
Net loss
-$31,918K
(-114.04%↓ Y/Y)
Unrealized gain on
marketable securities
-$179K
(-110.59%↓ Y/Y)
Interest income
$2,270K
(1.07%↑ Y/Y)
Net loss before
income taxes
-$31,915K
(-121.45%↓ Y/Y)
Income tax expense
$3K
(-99.40%↓ Y/Y)
Total other income,
net
$2,257K
(-7.69%↓ Y/Y)
License
$3,750K
Product
$1,736K
Other (expense)
income
-$13K
(-106.53%↓ Y/Y)
Loss from operations
-$34,172K
(-102.72%↓ Y/Y)
Total revenue
$5,486K
(9.72%↑ Y/Y)
Total operating
expenses
$39,658K
(81.44%↑ Y/Y)
Selling, general and
administrative
$39,378K
(207.74%↑ Y/Y)
Cost of sales
$280K
Back